Despite the compelling evidence that local mCRP and FH are involved in the progression of AMD, it is unknown whether systemic mCRP is altered in AMD patients and whether the systemic FH-mCRP axis could be a biomarker of AMD activity. Here, FH is linked to age-related macular degeneration.